Cervical ripening with mifepristone before labor induction: A randomized study

Obstetrics and Gynecology

Volumn 92, Issue 4, 1998, Pages 487-492

  Giacalone, P L ^a,b,c   Targosz, V ^a,b,c   Laffargue, F ^a,b,c   Boog, G ^a,b,c   Faure, J M ^a,b,c  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b SANOFI   (France)

^c Pavillon Mère et Enfant ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

MIFEPRISTONE; PLACEBO;

APGAR SCORE; ARTICLE; BLOOD PH; CESAREAN SECTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FETUS HEART RATE; GLUCOSE BLOOD LEVEL; HUMAN; LABOR INDUCTION; PRIORITY JOURNAL; PROLONGED PREGNANCY; RANDOMIZED CONTROLLED TRIAL; UMBILICAL CORD BLOOD; UTERINE CERVIX RIPENING;

ABORTIFACIENT AGENTS, STEROIDAL; ADULT; APGAR SCORE; CERVICAL RIPENING; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYDROCORTISONE; INFANT, NEWBORN; MIFEPRISTONE; PREGNANCY;

EID: 0031706245     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1016/s0029-7844(98)00225-7     Document Type: Article

References (11)

1. 2 gel for preinduction cervical ripening: Clinical trial results. J Reprod Med 1993;38:78- 82.
2. Couzinet B, Lestrat N, Ulmann A, Baulieu EE, Schaison G. Termination of early pregnancy by the progesterone antagonist RU 486 (mifepristone). N Engl J Med 1986;315:1565-70.
3. Urqhuart DR, Templeton AA. Mifepristone (RU 486) for cervical priming prior to surgically induced abortion in the late first trimester. Contraception 1990;42:191-9.
4. Rodger MW, Baird DT. Pretreatment with mifepristone (RU 486) reduces interval between prostaglandin administration and expulsion in second trimester abortion. Br J Obstet Gynaecol 1990;97: 41-5.
5. Urquart DR, Bahzad C, Templeton AA. Efficacy of the antiprogestin mifepristone (RU486) prior to prostaglandin termination of pregnancy. Hum Reprod 1989;4:202-3.
6. Cabrol D, Dubois C, Cronje H, Gonnet JM, Guillot M, Maria B, et al. Induction of labor with mifepristone (RU 486) in intrauterine fetal death. Am J Obstet Gynecol 1990;163:540-2.
7. Frydman R, Lelaidier C, Baton C, Fernandez H, Vial M, Bouget P. Labor induction in women at term with mifepristone (RU486): A double-blind, randomized, placebo-controlled study. Obstet Gynecol 1992;80:972-5.
8. Romieu G, Maudelonde T, Ulmann A, Pujol H, Grenier T, Cavalie G, et al. The antiprogestin RU 486 in advanced breast cancer: Preliminary clinical trial. Bull Cancer 1987;74:455-61.
9. Hill NCW, Selinger M, Ferguson J, Mackenzie IZ. The placental transfer of mifepristone (RU 486) during the second trimester and its influence upon maternal and fetal steroid concentration. Br J Obstet Gynaecol 1990;97:406-11.
10. Wolf JP, Sinosich M, Anderson TL, Ulmann A, Baulieu EE, Hodgen GD. Progesterone antagonist (RU 486) for cervical dilatation, labor induction and delivery in monkeys: Effectiveness in combination with oxytocin. Am J Obstet Gynecol 1989;160:45-7.
11. Hill NCW, Selinger M, Ferguson J, Lopez Bernal A, Mackenzie IZ. The physiological and clinical effects of progesterone inhibition with mifepristone (RU486) in the second trimester. Br J Obstet